1. Home
  2. INAB vs YAAS Comparison

INAB vs YAAS Comparison

Compare INAB & YAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • YAAS
  • Stock Information
  • Founded
  • INAB 2016
  • YAAS 2018
  • Country
  • INAB United States
  • YAAS China
  • Employees
  • INAB N/A
  • YAAS N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • YAAS Computer Software: Prepackaged Software
  • Sector
  • INAB Health Care
  • YAAS Technology
  • Exchange
  • INAB Nasdaq
  • YAAS Nasdaq
  • Market Cap
  • INAB 8.7M
  • YAAS 9.5M
  • IPO Year
  • INAB 2021
  • YAAS 2024
  • Fundamental
  • Price
  • INAB $2.10
  • YAAS $0.08
  • Analyst Decision
  • INAB Strong Buy
  • YAAS
  • Analyst Count
  • INAB 2
  • YAAS 0
  • Target Price
  • INAB $108.00
  • YAAS N/A
  • AVG Volume (30 Days)
  • INAB 52.4K
  • YAAS 20.5M
  • Earning Date
  • INAB 11-11-2025
  • YAAS 07-14-2025
  • Dividend Yield
  • INAB N/A
  • YAAS N/A
  • EPS Growth
  • INAB N/A
  • YAAS N/A
  • EPS
  • INAB N/A
  • YAAS N/A
  • Revenue
  • INAB N/A
  • YAAS $581,862.00
  • Revenue This Year
  • INAB N/A
  • YAAS N/A
  • Revenue Next Year
  • INAB N/A
  • YAAS N/A
  • P/E Ratio
  • INAB N/A
  • YAAS N/A
  • Revenue Growth
  • INAB N/A
  • YAAS N/A
  • 52 Week Low
  • INAB $1.91
  • YAAS $0.06
  • 52 Week High
  • INAB $16.70
  • YAAS $7.00
  • Technical
  • Relative Strength Index (RSI)
  • INAB 43.89
  • YAAS 25.86
  • Support Level
  • INAB $1.91
  • YAAS $0.07
  • Resistance Level
  • INAB $2.26
  • YAAS $0.09
  • Average True Range (ATR)
  • INAB 0.11
  • YAAS 0.02
  • MACD
  • INAB -0.01
  • YAAS -0.00
  • Stochastic Oscillator
  • INAB 48.72
  • YAAS 5.81

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About YAAS Youxin Technology Ltd

Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.

Share on Social Networks: